1. BioTime Appoints Cavan Redmond to Its Board of Directors

    BioTime Appoints Cavan Redmond to Its Board of Directors

    ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a late-stage, clinical biotechnology company developing and commercializing products addressing degenerative diseases, announced the appointment of Cavan Redmond as an independent member of the Board of Directors ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content

    1. I believe BioTime's Renevia and OpRegen programs have the potential to offer paradigm-changing treatment options for patients. I am excited to join the BioTime board to help guide the leadership team during this transformational period in the company's evolution.
    2. We are excited and looking forward to adding Cavan's experience and energy to our Board.
  3. Topics Mentioned